Skip to main content

Table 1

From: 1048 Randomized controlled trial of the effect of rosiglitazone on carotid atherosclerosis in diabetic patients

 

Treatment Group

Carotid Plaque

RSG

Placebo

Total Wall Volume (mm3)

(N = 25)

(N = 29)

N

21

26

Baseline (mean ± SD)

1354 ± 532

1146 ± 550

End of Treatment (mean ± SD)

1348 ± 531

1134 ± 523

Change from Baseline (mean ± SD)

-5.7 ± 79.4

-12.1 ± 105

Model Adjusted Change from Baseline (mean ± SE)

12.7 ± 22.8

-2.9 ± 20.9

Difference from Placebo: mean (95% CI2)

15.7 (-39.5, 70.9)

-

P-value

0.57

-